Spots Global Cancer Trial Database for peritoneal
Every month we try and update this database with for peritoneal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer | NCT01416038 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | DPX-Survivac low dose cyclop... | 18 Years - | ImmunoVaccine Technologies, Inc. (IMV Inc.) | |
| EDMONd - Elemental Diet in Bowel Obstruction | NCT03150992 | Ovarian Cancer Ovarian Neoplas... Ovarian Disease Peritoneal Neop... Peritoneal Dise... Metastatic Ovar... Primary Periton... Abdominal Neopl... Bowel Obstructi... | Elemental 028 E... | 18 Years - 90 Years | Royal Surrey County Hospital NHS Foundation Trust | |
| Platinum-Resistant, Recurrent Epithelial Ovarian Cancer | NCT00484666 | Ovarian Cancer | 18 Years - | Carilion Clinic | ||
| Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy | NCT01113736 | Colon Cancer Rectal Cancer | AlloMEM™ | 18 Years - | University Hospitals Cleveland Medical Center | |
| A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer | NCT00683241 | Ovarian Cancer Peritoneal Canc... | DCVac-L | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma | NCT01519869 | Primary Periton... Ovarian Carcino... Fallopian Tube ... | neoadjuvant che... | 18 Years - | University of Kentucky | |
| Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy | NCT01113736 | Colon Cancer Rectal Cancer | AlloMEM™ | 18 Years - | University Hospitals Cleveland Medical Center | |
| A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis | NCT01443260 | Peritoneal Carc... | GL-ONC1 | 18 Years - | Genelux Corporation | |
| Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC | NCT04104334 | Hyperthermia Colorectal Neop... Oxaliplatin | Remifentanil in... Remifentanil in... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| Fermented Wheat Germ Extract in Women With Ovarian Cancer | NCT02411565 | Ovarian Cancer | Fermented Wheat... Placebo Standard of Car... Quality of Life... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies | NCT02963831 | Colorectal Canc... Ovarian Cancer Appendiceal Can... | ONCOS-102 Durvalumab Cyclophosphamid... | 18 Years - | Ludwig Institute for Cancer Research | |
| Accelerating Gastrointestinal Recovery | NCT01704651 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Alvimopan Placebo | 18 Years - | Mayo Clinic | |
| Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer | NCT01220154 | Ovarian Cancer Fallopian Tube ... Primary Periton... No Prior Chemot... | Paclitaxel Carboplatin Bevacizumab | 18 Years - 90 Years | Ohio State University Comprehensive Cancer Center | |
| Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer | NCT03754569 | Epithelial Ovar... | Peritoneal biop... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis | NCT01342653 | Peritoneal Carc... Gastric Cancer | Intraperitoneal... | 18 Years - 64 Years | Hospital General Universitario Gregorio Marañon | |
| Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer | NCT00928642 | Ovarian Cancer Primary Periton... | imatinib mesyla... Gemcitabine Int... | 18 Years - | Henry M. Jackson Foundation for the Advancement of Military Medicine | |
| A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer | NCT00683241 | Ovarian Cancer Peritoneal Canc... | DCVac-L | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients | NCT02470299 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Ketorolac Placebo | 18 Years - | New Mexico Cancer Care Alliance | |
| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
| Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer | NCT00928642 | Ovarian Cancer Primary Periton... | imatinib mesyla... Gemcitabine Int... | 18 Years - | Henry M. Jackson Foundation for the Advancement of Military Medicine | |
| Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer | NCT01416038 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | DPX-Survivac low dose cyclop... | 18 Years - | ImmunoVaccine Technologies, Inc. (IMV Inc.) | |
| Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer | NCT00047632 | Ovarian Carcino... Peritoneal Carc... | Interferon gamm... | - | InterMune | |
| A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study | NCT01271959 | Solid Organ Tum... | 18 Years - | Precision Therapeutics | ||
| Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer | NCT00314678 | Epithelial Ovar... Primary Periton... | Topotecan Cisplatin Paclitaxel | 18 Years - | University of California, Irvine | |
| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
| Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin | NCT02017678 | Ovarian Cancer | JX-594 | 18 Years - | Mount Sinai Hospital, Canada | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| EDMONd - Elemental Diet in Bowel Obstruction | NCT03150992 | Ovarian Cancer Ovarian Neoplas... Ovarian Disease Peritoneal Neop... Peritoneal Dise... Metastatic Ovar... Primary Periton... Abdominal Neopl... Bowel Obstructi... | Elemental 028 E... | 18 Years - 90 Years | Royal Surrey County Hospital NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
